UCB and Domino Data Lab Team Up

Innovation often begins with collaboration. When two industry leaders join forces, the benefits ripple far beyond their respective organizations. That's precisely what's happening with UCB and Domino Data Lab, a leading data science technology provider. Together, we’re reimagining how life sciences can leverage advanced technology to accelerate research, streamline workflows, and ultimately deliver better results for patients.

Our focus? Modernizing the Statistical Computing Environment (SCE), which is essential for clinical research, regulatory compliance, and data analysis in life sciences. Through this endeavor, we aim to create a unified, scalable, and innovative platform. This exciting partnership promises to advance clinical research and transform the way data is used in the pursuit of new therapies.

Addressing the Challenges of Data in Life Sciences 

The life sciences industry has always been data-intensive, requiring robust tools to analyse, interpret, and make evidence-based decisions. Traditional systems for statistical computing, while valuable, often lack the flexibility and scale needed to meet today’s demands. Clinical trials are more complex, regulations are more stringent, and the volume of data continues to grow.

UCB recognized this challenge and saw an opportunity to take action. By teaming up with Domino Data Lab, we are on a mission to modernize the SCE, a critical component of our research and development processes. The goal isn’t just about upgrading technology; it’s about creating a platform that fosters innovation, streamlines collaboration, and ensures compliance with global standards.

The Vision Behind the Modernized SCE

At the heart of this collaboration is a clear vision for the future. UCB and Domino Data Lab are working together to create a cloud-enabled platform that integrates popular data tools like SAS, R, and Python. This unified framework will empower researchers and data scientists with more streamlined access to the technologies they need, improving both efficiency and outcomes.

By integrating advanced metadata and workflow management systems, this platform will prepare UCB for responsible data reuse and better oversight of complex research processes. For UCB, this means accelerating drug development, enhancing data-driven decision-making, and ultimately improving patient care.

What This Means for Patients and Researchers

The benefits of a modernized SCE are both immediate and far-reaching. For researchers and data scientists, having access to a unified, scalable system means less time wrestling with siloed tools and more time focusing on what matters most: unlocking insights to drive new therapies.

For patients, we aim to accelerate clinical studies, improve data analysis, and reduce the time it takes to bring new treatments to market. Additionally, leveraging large-scale data analysis enhances the ability to predict how therapies will perform in real-world scenarios, enabling more personalized and effective treatment options.

Looking Ahead

The collaboration between UCB and Domino Data Lab exemplifies what’s possible when expertise and innovation converge. Together, we aim to not just build a next-generation SCE; we’re setting a new standard for how data is harnessed to improve lives.

This initiative reflects UCB’s broader commitment to uncovering the root causes of diseases, understanding patient populations deeply, and accelerating research pipelines. By adopting cutting-edge technologies and fostering collaboration, they are paving the way for a brighter future in healthcare.

Whether you’re a researcher, a clinician, or a patient, the benefits of such advancements are clear. They represent a healthcare system that’s faster, smarter, and more connected to the needs of those it serves.

It’s an inspiring reminder of the power of collaboration and the role technology plays in creating a healthier, more innovative future for all.

You can read the full press release here.